Next Best Treatment for Inadequately Controlled Anxiety on Hydroxyzine

Recommended First-Line Pharmacotherapy

• The American Academy of Neuropsychopharmacology recommends SSRIs as the guideline-recommended first-line pharmacotherapy for anxiety disorders in adults, with strong evidence supporting their efficacy 1
• The Japanese Society of Anxiety and Related Disorders/Japanese Society of Neuropsychopharmacology specifically recommends SSRIs as first-line treatment (GRADE 2C recommendation) 1
• Serotonin-norepinephrine reuptake inhibitors (SNRIs) such as venlafaxine are recommended as an alternative first-line option by the American Academy of Neuropsychopharmacology 1

Practical Implementation Strategy

• The American Academy of Child and Adolescent Psychiatry recommends beginning with a subtherapeutic dose to minimize initial anxiety or agitation, which can be an early adverse effect of SSRIs, and increase the dose in small increments at 1-2 week intervals for shorter half-life SSRIs or 3-4 week intervals for longer half-life SSRIs 2
• The American Academy of Child and Adolescent Psychiatry suggests continuing titration until optimal benefit-to-harm ratio is achieved and remission occurs 2

Important Caveats and Monitoring

• The American Academy of Child and Adolescent Psychiatry warns that paroxetine, fluvoxamine, and sertraline can cause withdrawal symptoms if doses are missed or abruptly discontinued, making adherence counseling particularly important 2
• The American Academy of Child and Adolescent Psychiatry suggests considering combination therapy with CBT plus an SSRI if monotherapy fails, as it showed superior outcomes compared to either treatment alone in pediatric populations 2